- Drug Pipelines
- December 2022
- 30 Pages
Global
From €2542EUR$2,750USD£2,143GBP
- Report
- September 2022
- 95 Pages
Global
From €3651EUR$3,950USD£3,077GBP
- Report
- January 2022
- 60 Pages
Global
From €3651EUR$3,950USD£3,077GBP
- Drug Pipelines
- January 2022
- 100 Pages
Global
From €5268EUR$5,700USD£4,441GBP
- Report
- January 2022
- 60 Pages
Global
From €3651EUR$3,950USD£3,077GBP
- Report
- January 2022
- 60 Pages
Global
From €3651EUR$3,950USD£3,077GBP
- Report
- January 2022
- 200 Pages
Global
From €6932EUR$7,500USD£5,843GBP
- Report
- January 2022
- 60 Pages
Global
From €3651EUR$3,950USD£3,077GBP
- Report
- January 2022
- 60 Pages
Global
From €3651EUR$3,950USD£3,077GBP
- Report
- January 2022
- 60 Pages
Global
From €3651EUR$3,950USD£3,077GBP
- Report
- January 2022
- 90 Pages
Global
From €1848EUR$2,000USD£1,558GBP
- Report
- January 2022
- 90 Pages
Global
From €1848EUR$2,000USD£1,558GBP
- Report
- February 2021
- 35 Pages
Global
From €3004EUR$3,250USD£2,532GBP
- Report
- December 2020
- 60 Pages
Global
From €3004EUR$3,250USD£2,532GBP
- Report
- July 2019
Global
From €924EUR$1,000USD£779GBP
- Report
- August 2024
- 111 Pages
From €3189EUR$3,450USD£2,688GBP
- Report
- April 2024
- 65 Pages
China
From €3189EUR$3,450USD£2,688GBP
- Report
- April 2024
- 158 Pages
Global
From €4113EUR$4,450USD£3,467GBP
- Report
- March 2024
- 150 Pages
Global
From €4113EUR$4,450USD£3,467GBP
- Report
- March 2024
- 229 Pages
Global
From €4113EUR$4,450USD£3,467GBP

The Dermatological Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin conditions, including acne, eczema, psoriasis, and skin cancer. Dermatological drugs are typically administered topically, although some may be taken orally.
The Dermatological Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies are engaged in research and development of new drugs, as well as marketing and distribution of existing products. Additionally, many smaller companies are involved in the production of generic dermatological drugs. Show Less Read more